NasdaqCM - Delayed Quote USD

CytoMed Therapeutics Limited (GDTC)

2.0800
-0.0550
(-2.58%)
At close: June 13 at 4:00:00 PM EDT
2.0100
-0.07
(-3.37%)
After hours: June 13 at 5:27:57 PM EDT
Currency in SGD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
69.5010
69.5010
0
0
0
Cost of Revenue
17.1210
17.1210
0
0
--
Gross Profit
52.3800
52.3800
0
0
--
Operating Expense
3,182.9080
3,182.9080
3,842.8460
1,856.5660
1,728.1830
Operating Income
-3,130.5280
-3,130.5280
-3,842.8460
-1,856.5660
-1,728.1830
Net Non Operating Interest Income Expense
297.3570
297.3570
234.4370
-123.0780
-114.3270
Other Income Expense
311.3100
311.3100
-524.1080
-1,150.1680
-209.3930
Pretax Income
-2,521.8610
-2,521.8610
-4,132.5170
-3,129.8120
-2,051.9030
Tax Provision
0
0
0.6530
1.6400
0
Net Income Common Stockholders
-2,516.6980
-2,516.6980
-4,132.8960
-3,131.2090
-2,051.6500
Diluted NI Available to Com Stockholders
-2,516.6980
-2,516.6980
-4,132.8960
-3,131.2090
-2,051.6500
Basic EPS
-0.22
--
-0.39
-0.29
-0.19
Diluted EPS
-0.22
--
-0.39
-0.29
-0.19
Basic Average Shares
11,539.8340
--
10,630.3440
10,939.8190
10,939.8190
Diluted Average Shares
11,539.8340
--
10,630.3440
10,939.8190
10,939.8190
Rent Expense Supplemental
3.2150
3.2150
1.7030
2.2010
1.9970
Total Expenses
3,200.0290
3,200.0290
3,842.8460
1,856.5660
1,728.1830
Net Income from Continuing & Discontinued Operation
-2,516.6980
-2,516.6980
-4,132.8960
-3,131.2090
-2,051.6500
Normalized Income
-2,814.2430
-2,814.2430
-3,805.7465
-3,109.5111
-2,042.1690
Interest Income
317.6700
317.6700
285.7190
2.0970
3.3690
Interest Expense
20.3130
20.3130
51.2820
125.1750
117.6960
Net Interest Income
297.3570
297.3570
234.4370
-123.0780
-114.3270
EBIT
-2,501.5480
-2,501.5480
-4,081.2350
-3,004.6370
-1,934.2070
EBITDA
-2,166.1850
-2,166.1850
-3,700.0870
-2,611.7700
-1,604.3290
Reconciled Cost of Revenue
17.1210
17.1210
0
0
--
Reconciled Depreciation
335.3630
335.3630
381.1480
392.8670
329.8780
Net Income from Continuing Operation Net Minority Interest
-2,516.6980
-2,516.6980
-4,132.8960
-3,131.2090
-2,051.6500
Total Unusual Items Excluding Goodwill
297.5450
297.5450
-394.1560
-26.1420
-9.4810
Total Unusual Items
297.5450
297.5450
-394.1560
-26.1420
-9.4810
Normalized EBITDA
-2,463.7300
-2,463.7300
-3,305.9310
-2,585.6280
-1,594.8480
Tax Rate for Calcs
0
0
0.0002
0.0002
0
Tax Effect of Unusual Items
0
0
-67.0065
-4.4441
0
12/31/2021 - 4/14/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HSTOQ Histogen Inc.
0.0177
-43.00%
 
CYTOF Altamira Therapeutics Ltd.
0.0710
-11.25%
 
ANEB Anebulo Pharmaceuticals, Inc.
1.3900
+9.45%
 
TELO Telomir Pharmaceuticals, Inc.
1.9600
-2.00%
 
PHVS Pharvaris N.V.
16.70
-3.08%
 
APLM Apollomics, Inc.
6.07
-12.24%
 
TCRT Alaunos Therapeutics, Inc.
3.0750
+2.40%
 
IMMX Immix Biopharma, Inc.
2.3500
-5.62%
 
LTRN Lantern Pharma Inc.
3.0500
-5.57%
 
NBY NovaBay Pharmaceuticals, Inc.
0.6000
-6.77%